Cargando…
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
Duchenne muscular dystrophy (DMD) is a progressive muscle-wasting disorder. It is caused by loss-of-function mutations in the dystrophin gene. Currently, there is no cure. A highly promising therapeutic strategy is to replace or repair the defective dystrophin gene by gene therapy. Numerous animal m...
Autores principales: | McGreevy, Joe W., Hakim, Chady H., McIntosh, Mark A., Duan, Dongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348559/ https://www.ncbi.nlm.nih.gov/pubmed/25740330 http://dx.doi.org/10.1242/dmm.018424 |
Ejemplares similares
-
Night Activity Reduction is a Signature Physiological Biomarker for Duchenne Muscular Dystrophy Dogs
por: Hakim, Chady H., et al.
Publicado: (2015) -
Quantitative Phenotyping of Duchenne Muscular Dystrophy Dogs by Comprehensive Gait Analysis and Overnight Activity Monitoring
por: Shin, Jin-Hong, et al.
Publicado: (2013) -
Dystrophin Deficiency Compromises Force Production of the Extensor Carpi Ulnaris Muscle in the Canine Model of Duchenne Muscular Dystrophy
por: Yang, Hsiao T., et al.
Publicado: (2012) -
Non-invasive evaluation of muscle disease in the canine model of Duchenne muscular dystrophy by electrical impedance myography
por: Hakim, Chady H., et al.
Publicado: (2017) -
Early loss of ambulation is not a representative clinical feature in Duchenne muscular dystrophy dogs: remarks on the article of Barthélémy et al.
por: Duan, Dongsheng, et al.
Publicado: (2015)